|
|
|
Insider
Information: |
Levin Alan G |
Relationship: |
Director |
City: |
New York |
State: |
NY |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
4 |
|
Direct
Shares |
709,295 |
|
Indirect Shares
|
19,963 |
|
|
Direct
Value |
$10,286,471 |
|
|
Indirect Value
|
$578,328 |
|
|
Total
Shares |
729,258 |
|
|
Total
Value |
$10,864,799 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
1
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
1
|
0
|
|
|
|
Gain/Loss Ratio : |
-1.0
|
0.0
|
Percentage
Gain/Loss : |
-100.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Pfizer Inc |
PFE |
Senior Vice President |
2007-05-08 |
340,061 |
2007-05-08 |
19,963 |
Premium* |
|
Endo Health Solutions Inc |
ENDP |
EVP, Chief Financial O... |
2013-06-01 |
69,431 |
|
0 |
Premium* |
|
Cervomed Ord Shs |
CRVO |
Director |
2016-01-08 |
248,032 |
2016-01-08 |
0 |
Premium* |
|
Biocryst Pharmaceuticals Inc |
BCRX |
Director |
2024-06-12 |
51,771 |
2021-08-31 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
ENDP |
Endo Health Solutions Inc |
EVP, Chief Financial Officer |
|
2013-06-01 |
4 |
D |
$36.30 |
$158,849 |
D/D |
(4,376) |
69,431 |
0 |
- |
|
ENDP |
Endo Health Solutions Inc |
EVP, Chief Financial Officer |
|
2010-12-07 |
4 |
S |
$36.04 |
$599,237 |
D/D |
(16,627) |
6,577 |
0 |
- |
|
ENDP |
Endo Health Solutions Inc |
EVP, Chief Financial Officer |
|
2012-02-23 |
4 |
D |
$34.79 |
$57,438 |
D/D |
(1,651) |
2,441 |
0 |
- |
|
ENDP |
Endo Health Solutions Inc |
EVP, Chief Financial Officer |
|
2012-06-01 |
4 |
D |
$31.87 |
$136,977 |
D/D |
(4,298) |
6,577 |
0 |
- |
|
ENDP |
Endo Health Solutions Inc |
EVP, Chief Financial Officer |
|
2013-02-26 |
4 |
D |
$28.09 |
$95,309 |
D/D |
(3,393) |
2,425 |
0 |
- |
|
PFE |
Pfizer Inc |
Senior Vice President |
|
2007-05-08 |
4 |
S |
$27.34 |
$388,501 |
D/D |
(14,210) |
340,061 |
0 |
- |
|
PFE |
Pfizer Inc |
Senior Vice President |
|
2007-05-07 |
4 |
S |
$26.96 |
$3,835,830 |
D/D |
(141,938) |
354,271 |
0 |
- |
|
PFE |
Pfizer Inc |
Senior Vice President |
|
2006-02-27 |
4 |
D |
$26.55 |
$57,693 |
D/D |
(2,173) |
362,174 |
|
- |
|
PFE |
Pfizer Inc |
Senior Vice President |
|
2006-08-16 |
4 |
S |
$26.38 |
$854,712 |
D/D |
(32,400) |
369,147 |
|
- |
|
PFE |
Pfizer Inc |
Senior Vice President |
|
2006-02-23 |
4 |
D |
$26.20 |
$510,166 |
D/D |
(19,472) |
364,347 |
|
- |
|
PFE |
Pfizer Inc |
Senior Vice President |
|
2006-04-07 |
4 |
D |
$26.05 |
$755 |
D/D |
(29) |
362,204 |
|
- |
|
ENDP |
Endo Health Solutions Inc |
EVP, Chief Financial Officer |
|
2012-12-31 |
4 |
D |
$25.89 |
$368,596 |
D/D |
(14,237) |
35,917 |
0 |
- |
|
PFE |
Pfizer Inc |
Senior Vice President |
|
2007-02-22 |
4 |
D |
$25.87 |
$475,025 |
D/D |
(18,362) |
416,802 |
0 |
- |
|
PFE |
Pfizer Inc |
Senior Vice President |
|
2007-03-23 |
4 |
D |
$25.66 |
$333,914 |
D/D |
(13,013) |
404,099 |
0 |
- |
|
PFE |
Pfizer Inc |
Senior Vice President |
|
2005-11-11 |
4 |
S |
$22.26 |
$267,120 |
D/D |
(12,000) |
306,787 |
0 |
- |
|
ENDP |
Endo Health Solutions Inc |
EVP, Chief Financial Officer |
|
2010-06-01 |
4 |
D |
$20.72 |
$89,055 |
D/D |
(4,298) |
6,577 |
0 |
- |
|
ENDP |
Endo Health Solutions Inc |
EVP, Chief Financial Officer |
|
2010-12-13 |
4/A |
OE |
$20.09 |
$99,988 |
D/D |
4,977 |
11,554 |
0 |
- |
|
ENDP |
Endo Health Solutions Inc |
EVP, Chief Financial Officer |
|
2012-11-15 |
4 |
OE |
$20.09 |
$199,976 |
D/D |
9,954 |
18,131 |
0 |
- |
|
PFE |
Pfizer Inc |
Senior Vice President |
|
2007-05-07 |
4 |
OE |
$18.35 |
$1,651,500 |
D/D |
90,000 |
496,209 |
0 |
- |
|
BCRX |
Biocryst Pharmaceuticals ... |
Director |
|
2022-02-28 |
4 |
A |
$16.61 |
$9,999 |
D/D |
602 |
2,059 |
0 |
- |
|
ENDP |
Endo Health Solutions Inc |
EVP, Chief Financial Officer |
|
2010-12-07 |
4 |
OE |
$16.51 |
$374,500 |
D/D |
21,604 |
11,554 |
0 |
- |
|
BCRX |
Biocryst Pharmaceuticals ... |
Director |
|
2021-08-31 |
4 |
A |
$15.92 |
$9,998 |
D/D |
628 |
628 |
0 |
- |
|
BCRX |
Biocryst Pharmaceuticals ... |
Director |
|
2022-08-31 |
4 |
A |
$13.90 |
$11,245 |
D/D |
809 |
16,872 |
0 |
- |
|
BCRX |
Biocryst Pharmaceuticals ... |
Director |
|
2022-11-30 |
4 |
A |
$13.36 |
$11,249 |
D/D |
842 |
17,714 |
0 |
- |
|
PFE |
Pfizer Inc |
officerTitle |
|
2005-12-16 |
4 |
OE |
$12.42 |
$58,796 |
D/D |
4,734 |
310,187 |
|
- |
|
25 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|